112 related articles for article (PubMed ID: 9594181)
21. Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride.
Andriole GL; Marberger M; Roehrborn CG
J Urol; 2006 May; 175(5):1657-62. PubMed ID: 16600723
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
Welch HG; Schwartz LM; Woloshin S
J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
[TBL] [Abstract][Full Text] [Related]
23. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
Brawer MK; Cheli CD; Neaman IE; Goldblatt J; Smith C; Schwartz MK; Bruzek DJ; Morris DL; Sokoll LJ; Chan DW; Yeung KK; Partin AW; Allard WJ
J Urol; 2000 May; 163(5):1476-80. PubMed ID: 10751861
[TBL] [Abstract][Full Text] [Related]
24. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
[TBL] [Abstract][Full Text] [Related]
25. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
Rahardjo D; Kamil ST; Pakasi LS
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
[TBL] [Abstract][Full Text] [Related]
26. Age-associated increase of prostate-specific antigen in a high level of men visiting urological clinics.
Kobayashi T; Kinoshita H; Nishizawa K; Mitsumori K; Ogawa O; Kamoto T
Int J Urol; 2005 Aug; 12(8):733-8. PubMed ID: 16174047
[TBL] [Abstract][Full Text] [Related]
27. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.
Porter MP; Stanford JL; Lange PH
Prostate; 2006 Jul; 66(10):1044-51. PubMed ID: 16598738
[TBL] [Abstract][Full Text] [Related]
28. [Prostate specific antigen: a role of PSA in the diagnosis of prostate cancer].
Nutahara K; Higashihara E
Rinsho Byori; 2001 Oct; 49(10):963-6. PubMed ID: 11769472
[TBL] [Abstract][Full Text] [Related]
29. Ejaculation increases the serum prostate-specific antigen concentration.
Tchetgen MB; Song JT; Strawderman M; Jacobsen SJ; Oesterling JE
Urology; 1996 Apr; 47(4):511-6. PubMed ID: 8638359
[TBL] [Abstract][Full Text] [Related]
30. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.
Loeb S; Roehl KA; Antenor JA; Catalona WJ; Suarez BK; Nadler RB
Urology; 2006 Feb; 67(2):316-20. PubMed ID: 16442597
[TBL] [Abstract][Full Text] [Related]
31. The patients less than 50 years: is there a need to lower the PSA cutoff point?
Hekal IA
Prostate Cancer Prostatic Dis; 2009; 12(2):148-51. PubMed ID: 18825164
[TBL] [Abstract][Full Text] [Related]
32. Age-related free PSA, total PSA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males.
Kao CH
Anticancer Res; 1997; 17(2B):1361-5. PubMed ID: 9137499
[TBL] [Abstract][Full Text] [Related]
33. Age-specific reference range for serum prostate-specific antigen in Sudanese men.
Abdrabo AA; Fadlalla AI; Fadl-Elmula IM
Saudi Med J; 2011 Sep; 32(9):930-2. PubMed ID: 21894356
[TBL] [Abstract][Full Text] [Related]
34. Temporal (circadian) and functional relationship between prostate-specific antigen and testosterone in healthy men.
Mermall H; Sothern RB; Kanabrocki EL; Quadri SF; Bremner FW; Nemchausky BA; Scheving LE
Urology; 1995 Jul; 46(1):45-53. PubMed ID: 7541585
[TBL] [Abstract][Full Text] [Related]
35. Physiologic variations of serum testosterone within the normal range do not affect serum prostate-specific antigen.
Monath JR; McCullough DL; Hart LJ; Jarow JP
Urology; 1995 Jul; 46(1):58-61. PubMed ID: 7541587
[TBL] [Abstract][Full Text] [Related]
36. PSA and early prostate cancer detection: the importance of age-specific reference ranges.
Oesterling JE
Can J Oncol; 1994 Nov; 4 Suppl 1():52-6. PubMed ID: 8853490
[No Abstract] [Full Text] [Related]
37. Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values.
Semjonow A; Brandt B; Oberpenning F; Roth S; Hertle L
Prostate Suppl; 1996; 7():3-16. PubMed ID: 8950358
[TBL] [Abstract][Full Text] [Related]
38. Age-specific reference ranges for PSA in the detection of prostate cancer.
DeAntoni EP
Oncology (Williston Park); 1997 Apr; 11(4):475-82, 485; discussion 485-6, 489. PubMed ID: 9130271
[TBL] [Abstract][Full Text] [Related]
39. [Detection of prostate cancer in urological practice: clinical establishment of serum PSA reference values by age].
Yamazaki H; Suzuki Y; Madarame A; Katoh N; Masuda F; Ohishi ; Endo K
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):702-9. PubMed ID: 8709448
[TBL] [Abstract][Full Text] [Related]
40. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older.
Oesterling JE; Jacobsen SJ; Cooner WH
J Urol; 1995 Apr; 153(4):1160-3. PubMed ID: 7532725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
